mRNA-1273SARS-CoV-2Beta

Kizzmekia S Corbett1, Matthew Gagne1, Danielle A Wagner1

  • 1Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Science (New York, N.Y.)
|October 21, 2021
PubMed
概括

用mRNA-1273或mRNA-1273.β进行增强疫苗接种,增强了对SARS-CoV-2关注变体 (VOC) 的中和抗体反应. 这种免疫增强减少了非人类灵长类动物的病毒复制.